Data demonstrate efficacy of more flexible dose of regorafenib to relieve side-effects in mCRC patients

ScienceDaily
Jul 6, 2019, 12:34 pm1.7k ptsInterestingTop
Some of the adverse events related to the use of regorafenib often limits its use in clinical practice. A study suggests the usefulness of a more flexible dosing, which improves patients' quality of life without jeopardizing efficacy.

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

FedEx believes $300M electric truck spend will save them $800M in diesel 129

Hasta la vista, baby – Figure F.02 humanoid robots decommissioned, T2-style 124

New Colorado neighborhood could offer glimpse into the future of home energy use 120

HyFlux’s Superconducting Motor Might Work. Hydrogen Aviation Is The Hard Part. 112

Today's emissions choices could limit Antarctic ice loss and sea-level rise for coastal communities 109

Europe EV Sales Report: Record Month — BEVs Reach 30% Market Share! 107

How can the same El Niño cause drought in one part of the world and floods in another? 106

Australian Government Accelerates Renewable Energy Transition 104

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.